Dr. Gilks, Blake MD, FRCPC Academic Ranks (s): Professor Emeritus, UBC, Co-Founder, Ovarian Cancer Research Program (OVCARE) Affiliations (s): VGH/VCHRI
[email protected] Short Bio Academic Research Teaching Blake is a Professor Emeritus in the Dept of Pathology and Laboratory Medicine, at the University of British Columbia. Dr. Blake Gilks is Professor in the Dept of Pathology and Laboratory Medicine, at the University of British Columbia, in Vancouver Canada, and does clinical service work in the Division of Anatomic Pathology at Vancouver General Hospital, the site of the largest gynecological oncology program in the province of British Columbia, where he is Regi.
Department of Pathology & Laboratory Medicine, Magazine
Dr. Blake Gilks is a Professor in the Department of Pathology and Laboratory Medicine, at the University of British Columbia (UBC). Dr. Blake Gilks is a Professor Emeritus in the Dept of Pathology and Laboratory Medicine, at the University of British Columbia, and does clinical service work in the Division of Anatomic Pathology at Vancouver General Hospital, the site of the largest gynecological oncology program in the province of British Columbia, where he is Regional Medic. Pathology Outlines - C. Blake Gilks, M.D. Chapters By Subspecialty Autopsy & forensics Bone, joints & soft tissue Bone & joints Soft tissue Breast Clinical pathology Chemistry, toxicology & UA Coagulation Hematology & immune disorders Lab admin & management Microbiology & infectious diseases Transfusion medicine Cytopathology Dermatopathology Dr. Gilks, Blake MD, FRCPC e-mail:
[email protected] Lab Website http://www.ovcare.ca/about_us/research_group_leaders/ Basic Info Academic Research Teaching Basic Info OpenClose Academic Rank: Professor Emeritus, UBC, Co-Founder, Ovarian Cancer Research Affiliation (s): VGH/VCHRI Location: VGH/VCHRI Short Bio
Saving the lives of women with vulvar cancer VCH Research Institute
Dec 2020 C Blake Gilks's 539 research works with 38,308 citations and 10,945 reads, including: Letter to the Editor—p53 Immunohistochemical Staining and TP53 Gene Mutations in Endometrial Cancer:. Blake Gilks, Professor of Pathology and Laboratory Medicine graduated to emeritus status this August. He has accrued a stunning array of academic and clinical accomplishments, national and international recognition for his leadership in both gynecologic pathology and quality assurance, and a profoundly impactful record of mentorship. Commentary: novel observations and detailed molecular characterisation of mixed tumours and mesonephric‐like carcinosarcomas by Mirkovic et al. (2023) Histopathology. 2023-06 | Journal article. DOI: 10.1111/his.14900. Contributors : Jennifer Pors; Lynn Hoang; Naveena Singh; C Blake Gilks. Show more detail. Dr. Blake Gilks is a world-leading researcher in gynecological cancers and is a highly respected mentor. A Fredericton native, Dr. Gilks received a Bachelor of Science from UNB in 1981, before completing medical school at Dalhousie University and specialist training in anatomical pathology at the University of British Columbia. His ties to UNB.
Department of Pathology & Laboratory Medicine, Magazine
Blake Gilks, MD, FRCPC Co-Founder OVCARE | Professor Department of Pathology and Laboratory Medicine University of British Columbia C. Blake Gilks, David G. Huntsman, C. Blake Gilks & David G. Huntsman Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
C Blake Gilks, Christina I Selinger, Ben Davidson, Martin Köbel, Jonathan A Ledermann, Diana Lim, Anais Malpica, Yoshiki Mikami, Naveena Singh, Radhika Srinivasan, Russell Vang, Sigurd F Lax, W Glenn McCluggage
[email protected]. PMID: 29234950 DOI: 10.1007/s00428-017-2279-8 Abstract Uterine cancer was first subclassified based on anatomic site, separating those tumours arising from the endometrium from cervical cancers. There was then further subclassification of endometrial cancers based on cell type, and this correlated with the Type I and Type II.
Doctors of BC Terry Fox Medal profile Dr. Cyril Blake Gilks BCCRC
Abstract. Patients with high-grade subtypes of endometrial carcinoma (grade 3 endometrioid, serous, clear cell, or carcinosarcoma) have a relatively poor prognosis. The specific subtype may be used to guide patient management, but there is little information on the reproducibility of subtype diagnosis in cases of high-grade endometrial carcinoma. Dr. Blake Gilks Dr. Gilks is a Professor Emeritus in the Dept of Pathology and Laboratory Medicine, at the University of British Columbia, in Vancouver Canada, and does clinical service work in the Division of Anatomic Pathology at Vancouver General Hospital, the site of the largest gynecological oncology program in the province of British.
